Eterna Therapeutics Inc
Biotechnology
Healthcare
ERNA
5.18 M shares
NASDAQ US
traded
19 Sep 2025
listed
no
open
1.29
52 week high
27.75
high
1.40
52 week low
0.00
previous Close
1.38
P/E ratio
market cap
10.47 M
div yield
0
net incoming
-3.15 M
61.63 %
net profit margin
-314700000.00 %
0.00 %
operating incoming
-2.50 M
8.39 %
net change in cash
2.40 M
1.00 %
cash on hand
4.32 M
124.97 %
cost of revenue
55.00 K
0.00 %
top